false
0001025378
0001025378
2024-07-10
2024-07-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of report (Date of earliest event reported):
July 10, 2024
W. P. Carey Inc.
(Exact Name of Registrant as Specified in its Charter)
Maryland |
|
001-13779 |
|
45-4549771 |
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
One Manhattan West, 395 9th Avenue,
58th Floor
New York, New York |
|
10001 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (212) 492-1100
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, $0.001 Par Value |
|
WPC |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 10, 2024, W. P. Carey
Inc. (the “Company”) announced that John J. Park will step down as President of the Company effective September 30, 2024.
The separate role of President will be eliminated, and the title will be assumed by Jason Fox, the Company’s Chief Executive Officer,
effective October 1, 2024. Mr. Park will remain Senior Advisor to the Company through February 28, 2025 to ensure an orderly transition
of his duties to other members of the Company’s management team.
Mr. Park and the Company entered
into a letter agreement, dated July 9, 2024 (the “Separation Agreement”). Pursuant to the Separation Agreement, subject to
certain conditions, Mr. Park will be entitled to receive continued vesting of his outstanding unvested restricted stock units and performance
stock units through the date such units would otherwise have become vested in accordance with their terms. Mr. Park will not receive a
cash severance payment under the Separation Agreement.
The foregoing summary of the
Separation Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Separation
Agreement, which is attached as Exhibit 10.1 and incorporated herein by reference.
A copy of the Company’s
press release is attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: July 10, 2024 |
W. P. Carey Inc. |
|
|
|
By: |
/s/ Jason E. Fox |
|
|
Jason E. Fox |
|
|
Chief Executive Officer |
Exhibit 10.1
July 2, 2024
PERSONAL & CONFIDENTIAL
John J. Park
Dear John:
This letter,
including Exhibit A attached hereto, sets forth our mutual understanding and agreement concerning your transition and separation from
employment with W. P. Carey Inc. and its affiliates (the “Company”).
1.
You and the Company have mutually agreed that your last day of employment with the Company shall be the close of business on February
28, 2025 (the “Separation Date”). From the date of this letter agreement through September 30, 2024, you will retain
your current title of “President” and you will continue performing your current duties in good faith, including transitioning
your work. From October 1, 2024 through February 28, 2025 (the “Senior Advisor Period”), you will continue to be employed
by the Company and receive your current base salary and benefits. During the Senior Advisor Period, your title will be “Senior
Advisor” and you will remain available to the Company (by telephone, email, or in-person, as the Company may reasonably request)
to assist with matters arising out of your employment with the Company or any other relationship with the Company, including to assist
with an orderly transition of any of your responsibilities or projects, whether such matters are business-related, legal, or otherwise.
You agree and acknowledge that your employment with the Company is and remains at-will through the Separation Date. At the next regular
payroll date following the Separation Date, the Company will pay you for any earned but unpaid base salary. You will continue to be eligible
to receive a bonus for the 2024 calendar year, but you will not be eligible to receive a 2025 bonus or any grant of new equity in 2025.
No later than one week following the Separation Date you will return to the Company all Company property (including work-issued devices)
and documents in your possession. You agree to execute any documents necessary to effectuate your resignations from all officer or other
positions that you hold with the Company, including each of its subsidiaries and affiliates, as the Company shall reasonably request
to evidence any such resignation.
2.
The Company agrees that (i) all time-vesting restricted stock units and (ii) all performance
share units previously granted to you that remain outstanding and unvested as of the Separation Date shall be payable to you as though
you continued in employment through the date such units would otherwise have become vested in accordance with their terms. For the avoidance
of doubt, this means that, (x) in respect of your outstanding performance share units, you will receive payment, if any,
equal to the full amount that would otherwise have been paid to you at the end of the applicable three-year performance cycle based on
the actual performance during such period had you remained employed until the end of such period and (y) in respect of
your outstanding restricted stock units, such units will vest and the shares underlying such vested restricted stock units will be delivered
to you in accordance with the applicable governing documents, regardless of the Separation Date. The vesting terms set forth in this
paragraph 2 are contingent upon your (a) remaining employed through the Separation Date, (b) executing, delivering,
not revoking, and complying to the Company’s satisfaction with all of the terms of this letter agreement, (c) executing
and delivering the release attached hereto as Exhibit A on or within seven (7) days after the Separation Date, and (d) not
revoking such release in accordance with its terms following its execution and delivery.
W. P. Carey Inc.
One Manhattan West | 395
9th Avenue, 58th Floor | New York, NY 10001 | P: 212-492-1100 | F: 212-492-8922 | wpcarey.com
3.
Provided that (a) you timely sign, deliver, and comply with all terms of this letter agreement and do not revoke this letter agreement,
(b) you sign, deliver and comply with all the terms of the general release in the form attached hereto as Exhibit A on or within seven
(7) days after the Separation Date and do not revoke such general release, and (c) you properly and timely elect to continue your existing
medical and dental insurance coverage in accordance with the continuation requirements of COBRA, the Company will pay directly to the
insurance carrier 100% of the cost to you of the premium for such coverage for a period of thirty-six (36) months following the Separation
Date or until you qualify for any other company-sponsored medical/dental plans through a subsequent employer, whichever occurs sooner.
You agree to keep the Company informed as to your eligibility for benefits from a subsequent employer. Notwithstanding the foregoing,
in the event that the COBRA-reimbursement benefits under this paragraph 3 would violate or otherwise fail to comply with any new law,
rule or regulation, or as a result of any change in law, rule or regulation, the cost to the Company of providing you such benefits (including
for this purpose, any excise tax imposed on the Company as a result of providing such benefits to you) should exceed the cost to the
Company of providing an active employee of the Company with comparable benefits, the Company shall not be obligated to continue to provide
you such benefits.
4.
Notwithstanding anything in this letter agreement to the contrary, nothing in this letter agreement (including, without limitation,
the non-disparagement provisions in paragraph 5, the release provisions in paragraph 6, and the mandatory arbitration provisions in paragraph
9): (a) prohibits you from voluntarily communicating with, or providing information to, any government agency or other
regulator that is responsible for enforcing a law on behalf of the government regarding conduct or action undertaken or omitted to be
taken by the Company or any of its affiliates that you reasonably believe is illegal or in material non-compliance with any financial
disclosure or other regulatory requirement applicable to the Company or any of its affiliates; (b) prohibits you from providing
truthful testimony or accurate information in connection with any investigation being conducted into the business or operations of the
Company or any of its affiliates by any such government agency or other regulator; or (c) requires you to obtain the approval
of, or give notice to, the Company or any of its employees or representatives to take any action permitted under clauses (a) or (b).
Additionally, notwithstanding anything in this letter agreement to the contrary, your obligations set forth in this letter agreement
shall not be interpreted or applied in a manner that would conflict with your rights, if any, under the National Labor Relations Act.
W. P. Carey Inc.
One Manhattan West | 395
9th Avenue, 58th Floor | New York, NY 10001 | P: 212-492-1100 | F: 212-492-8922 | wpcarey.com
5.
Except as permitted pursuant to paragraph 4, you agree not to make any statement (and not to cause any other person to make any
statement), whether written or oral, which criticizes or is disparaging of the Company or which is intended to or could reasonably be
expected to damage the business or reputation of the Company or any of its affiliates, officers, directors or employees. The Company
agrees that it shall not instruct or authorize, where it has prior knowledge of it, any person to make any statement, whether written
or oral, which criticizes or disparages you or which is intended to or could reasonably be expected to damage your reputation. Nothing
in this paragraph 5 or this letter agreement shall be interpreted, however, to preclude you or the Company from making truthful statements
to the extent required by applicable law or regulation, in connection with any proceeding (regardless of whether between you and the
Company) or in the course of any regulatory or administrative inquiry, review or investigation.
6.
Subject to paragraph 4, you hereby fully and generally release, discharge and covenant not to sue the Company, each of its current
and former parents, subsidiaries, affiliates, predecessors and successors, and each of the foregoing entities’ respective current
and former officers, directors, shareholders, employees and representatives acting in their capacity as employees or representatives
(the “Company Releasees”) with respect to any and all claims, demands, costs, rights, causes of action, complaints,
losses, damages and all liability of whatever kind and nature, whether known or unknown, which you may have at the date you execute this
letter agreement or had at any time prior thereto, including, but not limited to, any and all claims which may in any way arise out of
or under, be connected with or relate to your employment at the Company, your activities at the Company, your separation from employment
at the Company, or the conduct of any of the foregoing Company Releasees.
Without limiting the generality
of the foregoing, you expressly agree and acknowledge that this release and covenant not to sue includes, but is not limited to, any
claim (a ) based on any federal, state or local statute, including, but not limited to, any statute relating to employment,
medical leave, retirement or disability, age, sex, pregnancy, race, national origin, sexual orientation or other form of discrimination,
including, but not limited to, all claims arising under Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment
Act of 1967, the Civil Rights Act of 1991, the Equal Pay Act, the Americans with Disabilities Act, the Employee Retirement Income Security
Act of 1974, the New York State Human Rights Law; the New York City Human Rights Law; (b ) for wrongful or retaliatory
termination of any kind; (c ) for fraud or fraud in the inducement; (d) for negligent misrepresentation;
(e ) relating to any implied or express contract, promise or agreement (whether oral or written); (f ) for
intentional or negligent infliction of emotional distress or harm, defamation or any other tort; (g ) for additional compensation,
severance pay or benefits of any kind; (h ) for breach of fiduciary duty; (i) for attorneys’ fees or
costs; or (j ) for promissory estoppel (collectively, the “Released Claims”).
W. P. Carey Inc.
One Manhattan West | 395
9th Avenue, 58th Floor | New York, NY 10001 | P: 212-492-1100 | F: 212-492-8922 | wpcarey.com
Notwithstanding the foregoing,
any Released Claims shall not include any rights or claims that cannot be waived by law, including, but not limited to, the rights to
file a discrimination charge with an administrative agency, participate in any federal, state or local agency investigation or to receive
an award from any law enforcement or regulatory agency that provides awards for providing information relating to a potential violation
of law; you do, however, agree to waive any right to recover money in connection with any such discrimination charge or discrimination-related
investigation. For the avoidance of doubt, nothing in this letter agreement limits your right to receive an award from any law enforcement
or regulatory agency that provides awards for providing information relating to a potential violation of law.
7.
You hereby agree, acknowledge and affirm each of the following: (a) that you fully understand the terms and
conditions stated in this letter agreement, and are executing this letter agreement with the intent to be legally bound thereby; (b)
that you have been encouraged by representatives of the Company to have this letter agreement reviewed by legal counsel of your own choosing
and that you have been given ample time to do so prior to signing it; (c) that you have had the opportunity to negotiate
concerning the terms of the letter agreement; (d) that you knowingly and voluntarily waive your rights to consider this
letter agreement for a full twenty-one (21) days; (e) that this letter agreement specifically applies to any rights or
claims you may have against the Company or any party released herein under the federal Age Discrimination in Employment Act of 1967,
29 U.S.C. § 621 et seq., as amended (“ADEA”); (f) that notwithstanding anything in this
letter agreement to the contrary, this letter agreement does not purport to waive rights or claims arising under ADEA that may arise
from acts or events occurring after the date that this letter agreement is signed by you; and (g) that you have the right
to revoke this letter agreement within seven (7) days following the date you execute this letter agreement. Any revocation of this letter
agreement must be in writing and received by the Company by the close of business on the seventh (7th) day following your
execution of this letter agreement and shall be delivered to Stacey L. Lamendola, (slamendola@wpcarey.com) W. P. Carey Inc., One
Manhattan West, 395 9th Ave., New York, NY 10001. Upon any revocation in accordance herewith, this letter agreement will be rendered
void and without effect and you shall not be entitled to the separation benefits hereunder.
8.
During the period of your continued employment with the Company and for a period of two (2) years following any termination thereof,
you shall not assist or encourage any other person to: (i) employ, hire, engage or be associated (as a shareholder, partner, employee,
consultant or in a similar capacity) with any employee or other person connected with the Company; (ii) induce any employee to leave
the employ of the Company or any of its affiliates; (iii) solicit the employment, of any employees on your own behalf or on behalf of
any other business enterprise; or (iv) otherwise interfere with the relationship of the Company or its affiliates with any person who
is or was employed during your employment.
W. P. Carey Inc.
One Manhattan West | 395
9th Avenue, 58th Floor | New York, NY 10001 | P: 212-492-1100 | F: 212-492-8922 | wpcarey.com
9.
This letter agreement shall be construed in accordance with the laws of the State of New York, without reference to its choice
of law principles that would apply the law of any other jurisdiction. Except as provided in paragraph 4, any controversy or claim arising
out of or under or relating to this letter agreement or the breach or alleged breach thereof, and any other claim which may in any way
arise out of or under, be connected with or relate to your employment at the Company, your activities at the Company, or your separation
from employment at the Company, shall, to the fullest extent permitted by law, be asserted and resolved solely by binding, confidential
arbitration before a sole arbitrator in New York, New York, administered by the American Arbitration Association under its Employment
Arbitration Rules and Mediation Procedures. Judgment on the award may be entered in any court having jurisdiction. Notwithstanding the
foregoing, nothing herein shall prevent any party from seeking injunctive relief in court or arbitration to prevent irreparable harm
pending conclusion of any arbitration proceeding. With respect to such injunctive relief in court, you and the Company do hereby irrevocably
submit to the sole jurisdiction of state and federal courts within New York State and waive any objections and defenses based upon forum,
venue, or personal or subject matter jurisdiction as they may relate to an application for such relief.
10.
This letter agreement represents the entire agreement between the parties as to the subject matters herein and supersedes all
prior and contemporaneous understandings and agreements with respect thereto.
11.
This letter agreement shall be binding upon and shall inure to the benefit of the parties hereto, their respective heirs, administrators,
beneficiaries, representatives, executors, successors and assigns. This letter agreement may not be amended except by a writing signed
by both parties. You agree and acknowledge that the benefits contained herein exceed, and are in full and final satisfaction of, any
other benefits or consideration to which you may be entitled from the Company, any of its parents, subsidiaries, affiliates, predecessors
or successors and any officers, directors, shareholders, employees or representatives of the foregoing.
12.
Waiver by a party of any breach of any provision of this letter agreement by the other party shall not operate nor be construed
as a waiver of any subsequent or other breach. No provision or breach of this letter agreement may be waived except by a written instrument
signed by the party waiving such provision or breach, which states that such party is waiving such provision or breach. If any provision
of this letter agreement is held to be illegal, void or unenforceable, such provision shall be of no force or effect. However, the illegality
or unenforceability of such provision shall have no effect upon, and shall not impair the legality or enforceability of, any other provision
of this letter agreement.
13.
This letter agreement may be executed in counterparts (including via facsimile or .pdf file), each of which shall be deemed an
original but all of which together shall constitute one and the same instrument.
[Signature Page Follows]
W. P. Carey Inc.
One Manhattan West | 395
9th Avenue, 58th Floor | New York, NY 10001 | P: 212-492-1100 | F: 212-492-8922 | wpcarey.com
If this letter completely and accurately
reflects the agreement between you and the Company, please sign, date and return this letter to Stacey L. Lamendola, (slamendola@wpcarey.com)
W. P. Carey Inc., One Manhattan West, 395 9th Ave., New York, NY 10001.
The offer embodied in this letter will
be formally withdrawn if you do not accept it by signing this letter and returning it to Stacey L. Lamendola no later than July 23, 2024.
|
Very truly yours, |
|
|
|
/s/ Jason Fox |
|
Jason Fox |
Accepted and Agreed to: |
|
|
|
/s/ John J. Park |
|
John J. Park |
|
|
|
Dated: July 9, 2024 |
|
W. P. Carey Inc.
One Manhattan West | 395
9th Avenue, 58th Floor | New York, NY 10001 | P: 212-492-1100 | F: 212-492-8922 | wpcarey.com
Exhibit A
GENERAL RELEASE OF CLAIMS
WHEREAS, I, John Park, have separated from employment
with W. P. Carey Inc. (together with its affiliates, the “Company”); and
WHEREAS, pursuant to that certain letter agreement
entered into between myself and the Company (the “Letter Agreement”), the Company has agreed to provide me with certain post-employment
benefits to which I would not have otherwise been entitled, contingent on my signing this General Release of Claims (this “Release”);
NOW, THEREFORE, in consideration of the promises
made by the Company in the Letter Agreement and for other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, I hereby agree as follows:
1. Subject
to paragraph 2, I hereby fully and generally release, discharge and covenant not to sue the Company, each of its current and former parents,
subsidiaries, affiliates, predecessors and successors, and each of the foregoing entities’ respective current and former officers,
directors, shareholders, employees and representatives acting in their capacity as employees or representatives (the “Company
Releasees”) with respect to any and all claims, demands, costs, rights, causes of action, complaints, losses, damages and all
liability of whatever kind and nature, whether known or unknown, which I may have at the date I execute this Release or had at any time
prior thereto, including, but not limited to, any and all claims which may in any way arise out of or under, be connected with or relate
to my employment at the Company, my activities at the Company, my separation from employment at the Company, or the conduct of any of
the foregoing Company Releasees.
Without limiting the generality of the foregoing, I expressly agree
and acknowledge that this release and covenant not to sue includes, but is not limited to, any claim (a ) based on any
federal, state or local statute, including, but not limited to, any statute relating to employment, medical leave, retirement or disability,
age, sex, pregnancy, race, national origin, sexual orientation or other form of discrimination, including, but not limited to, all claims
arising under Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act of 1967, the Civil Rights Act of 1991,
the Equal Pay Act, the Americans with Disabilities Act, the Employee Retirement Income Security Act of 1974, the New York State Human
Rights Law; the New York City Human Rights Law; (b ) for wrongful or retaliatory termination of any kind; (c
) for fraud or fraud in the inducement; (d ) for negligent misrepresentation; (e ) relating to any implied
or express contract, promise or agreement (whether oral or written); (f ) for intentional or negligent infliction of emotional
distress or harm, defamation or any other tort; (g ) for additional compensation, severance pay or benefits of any kind;
(h ) for breach of fiduciary duty; (i) for attorneys’ fees or costs; or (j ) for promissory
estoppel (collectively, the “Released Claims”).
W. P. Carey Inc.
One Manhattan West | 395
9th Avenue, 58th Floor | New York, NY 10001 | P: 212-492-1100 | F: 212-492-8922 | wpcarey.com
Notwithstanding the foregoing, any Released Claims shall not include
any rights or claims that cannot be waived by law, including, but not limited to, the rights to file a discrimination charge with an
administrative agency, participate in any federal, state or local agency investigation or to receive an award from any law enforcement
or regulatory agency that provides awards for providing information relating to a potential violation of law; I do, however, agree to
waive any right to recover money in connection with any such discrimination charge or discrimination-related investigation. For the avoidance
of doubt, nothing in this Release limits my right to receive an award from any law enforcement or regulatory agency that provides awards
for providing information relating to a potential violation of law.
2. Notwithstanding
anything in this Release to the contrary, nothing in this Release (including, without limitation, the release provisions in paragraph
1): (a) prohibits me from voluntarily communicating with, or providing information to, any government agency or other regulator
that is responsible for enforcing a law on behalf of the government regarding conduct or action undertaken or omitted to be taken by
the Company or any of its affiliates that I reasonably believe is illegal or in material non-compliance with any financial disclosure
or other regulatory requirement applicable to the Company or any of its affiliates; (b) prohibits me from providing truthful
testimony or accurate information in connection with any investigation being conducted into the business or operations of the Company
or any of its affiliates by any such government agency or other regulator; or (c) requires me to obtain the approval of,
or give notice to, the Company or any of its employees or representatives to take any action permitted under clauses (a) or (b). Additionally,
notwithstanding anything in this Release to the contrary, my obligations set forth in this Release shall not be interpreted or applied
in a manner that would conflict with my rights, if any, under the National Labor Relations Act.
3. I
hereby agree, acknowledge and affirm each of the following: (a) that I fully understand the terms and conditions stated
in this Release, and are executing this Release with the intent to be legally bound thereby; (b) that I have been encouraged
by representatives of the Company to have this Release reviewed by legal counsel of my own choosing and that I have been given ample
time to do so prior to signing it; (c) that I have had the opportunity to negotiate concerning the terms of this Release;
(d) that I knowingly and voluntarily waive my rights to consider this Release for a full twenty-one (21) days; (e)
that this Release specifically applies to any rights or claims I may have against the Company or any party released herein under the
federal Age Discrimination in Employment Act of 1967, 29 U.S.C. § 621 et seq., as amended (“ADEA”); (f)
that notwithstanding anything in this Release to the contrary, this Release does not purport to waive rights or claims arising under
ADEA that may arise from acts or events occurring after the date that this Release is signed by me; and (g) that I have
the right to revoke this Release within seven (7) days following the date I execute this Release. Any revocation of this Release must
be in writing and received by the Company by the close of business on the seventh (7th) day following my execution of this
Release and shall be delivered to Stacey L. Lamendola, (slamendola@wpcarey.com) W. P. Carey Inc., One Manhattan West, 395 9th
Ave., New York, NY 10001. Upon any revocation in accordance herewith, this Release will be rendered void and without effect and I shall
not be entitled to the separation benefits under the Letter Agreement.
W. P. Carey Inc.
One Manhattan West | 395
9th Avenue, 58th Floor | New York, NY 10001 | P: 212-492-1100 | F: 212-492-8922 | wpcarey.com
Accepted and Agreed to: |
|
|
|
|
|
John J. Park |
|
Dated: __________ ___, 2025
[Signature Page to General Release of Claims]
W. P. Carey Inc.
One Manhattan West | 395
9th Avenue, 58th Floor | New York, NY 10001 | P: 212-492-1100 | F: 212-492-8922 | wpcarey.com
Exhibit 99.1
W. P. Carey Announces Departure of President
John Park
NEW YORK, July 10, 2024 /PRNewswire/ -- W. P. Carey Inc. (NYSE: WPC),
a leading net lease REIT, today announced that John Park will step down as President of
the company effective September 30, 2024. Mr. Park will serve as Senior Advisor to the company through February 2025 and will continue
to serve as a Trustee of Net Lease Office Properties (NYSE: NLOP) and the W. P. Carey Foundation. The separate role of President will
be eliminated, and the title will be assumed by Jason Fox, the company’s Chief Executive Officer.
Mr. Park joined W. P. Carey in 1987, working alongside Founder Wm.
Polk Carey in various roles of increasing responsibility. He led many of W. P. Carey’s transformative transactions, including the
consolidation and NYSE listing of CPA:1–9 as Carey Diversified LLC in 1998, its merger with W. P. Carey & Co. Inc. in 2000,
W. P. Carey’s merger with CPA:15 and REIT conversion in 2012, and the company’s subsequent mergers with CPA:16, CPA:17 –
Global and CPA:18 – Global.
Mr. Fox said, "John has been an integral member of the W. P. Carey
team for nearly 37 years. His contributions to our success have been numerous and I have personally valued his insights, creativity,
and importantly, his friendship over the years. On behalf of the entire company, I want to thank John for the critical role he played
in shaping W. P. Carey."
"Having spent my entire career at W. P. Carey, I am proud to have
helped steer its growth and evolution from a private asset manager to the leading publicly traded net lease REIT it is today," Mr.
Park said. “It’s been a privilege to work with such a talented and passionate team, and I know that I will be leaving W. P.
Carey in a strong position with a bright future."
W. P. Carey Inc.
W. P. Carey ranks among the largest net lease
REITs with a well-diversified portfolio of high-quality, operationally critical commercial real estate, which includes 1,282 net lease
properties covering approximately 168 million square feet and a portfolio of 89 self-storage operating properties as of March 31, 2024.
With offices in New York, London, Amsterdam and Dallas, the company remains focused on investing primarily in single-tenant, industrial,
warehouse and retail properties located in the U.S. and Northern and Western Europe, under long-term net leases with built-in rent escalations.
www.wpcarey.com
v3.24.2
Cover
|
Jul. 10, 2024 |
Cover [Abstract] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Jul. 10, 2024
|
Entity File Number |
001-13779
|
Entity Registrant Name |
W. P. Carey Inc.
|
Entity Central Index Key |
0001025378
|
Entity Tax Identification Number |
45-4549771
|
Entity Incorporation, State or Country Code |
MD
|
Entity Address, Address Line One |
One Manhattan West
|
Entity Address, Address Line Two |
395 9th Avenue
|
Entity Address, Address Line Three |
58th Floor
|
Entity Address, City or Town |
New York
|
Entity Address, State or Province |
NY
|
Entity Address, Postal Zip Code |
10001
|
City Area Code |
212
|
Local Phone Number |
492-1100
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Title of 12(b) Security |
Common Stock, $0.001 Par Value
|
Trading Symbol |
WPC
|
Security Exchange Name |
NYSE
|
Entity Emerging Growth Company |
false
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 3 such as an Office Park
+ References
+ Details
Name: |
dei_EntityAddressAddressLine3 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
WP Carey (NYSE:WPC)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
WP Carey (NYSE:WPC)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024